Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome.
about
Alum, an aluminum-based adjuvant, induces Sjögren's syndrome-like disorder in miceUpdate on Pathogenesis of Sjögren's syndrome.R270C polymorphism leads to loss of function of the canine P2X7 receptor.The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
P2860
Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epistasis with HLA DR3 implica ...... of primary Sjögren's syndrome.
@en
Epistasis with HLA DR3 implica ...... of primary Sjögren's syndrome.
@nl
type
label
Epistasis with HLA DR3 implica ...... of primary Sjögren's syndrome.
@en
Epistasis with HLA DR3 implica ...... of primary Sjögren's syndrome.
@nl
prefLabel
Epistasis with HLA DR3 implica ...... of primary Sjögren's syndrome.
@en
Epistasis with HLA DR3 implica ...... of primary Sjögren's syndrome.
@nl
P2093
P2860
P50
P356
P1476
Epistasis with HLA DR3 implica ...... of primary Sjögren's syndrome
@en
P2093
Christopher J Lessard
Kathy L Sivils
Kristen K Skarratt
Maureen Rischmueller
Susan Lester
P2860
P2888
P356
10.1186/AR4248
P577
2013-06-02T00:00:00Z
P5875
P6179
1032557616